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T cell mediated autoimmune diabetes is characterized by immune cell infiltration of pancreatic islets and
destruction of insulin-producing β-cells. This study was designed to assess the effect of whey proteins (WP) on the
responsiveness of lymphocytes in rats after four months of Streptozotocin (STZ)-induced Type 1 diabetes (T1D). A
diabetic group was supplemented with WP daily for five weeks at a dose of 100 mg/kg. Ribonucleic acid (RNA) was
extracted from stimulated lymphocytes in order to analyse gene expressions using real time PCR and RT-PCR. PCR
results were confirmed with ELISA. The proliferation capacity of lymphocytes and their homing to the spleen were
studied. Antigen-activated lymphocytes showed that diabetes impaired the mRNA expression of the protein kinase
B (Akt1), Cdc42, and the co-stimulatory molecule, CD28, which are important for cell survival, actin polymerization
and T cell activation, respectively. Accordingly, proliferation of lymphocytes was found to be suppressed in diabetic
rats, both in vivo and in vitro. WP was found to restore Akt1, Cdc42 and CD28 mRNA expression during diabetes to
normal levels. WP, therefore, served to activate the proliferation of B lymphocytes in diabetic rats both in vivo and
in vitro. Although WP was found to up-regulate mRNA expression of both interleukin (IL)-2 and interferon gamma
(IFN-γ), it suppressed the proliferation activity of almost all T cell subsets. This was confirmed by WP normalizing the
structure and function of ß cells. Meanwhile, WP was found to down regulate the mRNA expression of Tumor
necrosis factor-alpha (TNF-α) and its programmed cell death-receptor (Fas). Taken together, the results of this study
provide evidence for the potential impact of WP in the treatment of immune impairment in T1D, suggesting that it
serves to reverse autoimmunity by suppressing autoreactive T cells and down regulating TNF-α and Fas, resulting in
improved pancreatic ß cell structure and function.
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Homeostasis within the immune system needs to select-
ively force the survival of useful lymphocytes in the cen-
tral lymphoid organs and antigen-reactive cells in the
periphery, whilst deleting strongly autoreactive cells in
the thymus and bone marrow [1]. CD4+ T-helper cells
differentiate into three subsets of effector cells: Th1,
Th2, and Th17. An overactive Th1 response can lead to
autoimmune diseases such as T1D [2]. T cell activation
involves multiple interactions with the cell surface,Correspondence: hossamebaid@yahoo.com
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unless otherwise stated.including co-stimulatory molecules such as CD28, and
signaling from cytokine or chemokine receptors [3]. Recent
studies provide evidence that CD28 co-stimulation of dif-
ferent cytokines is mediated by discrete signaling pathways,
one of which includes protein kinase B (Akt) [4] which is
known to protect cells against apoptosis [5]. Dysregulation
of Akt leads to diseases such as cancer, and diabetes as
well as cardiovascular and neurological diseases [6] and
schizophrenia [7]. Cdc42, a member of the Rho family of
GTPases, plays a role in cell motility and migration [8,9]
and regulates the dynamics of the cytoskeleton [10]. Runne
et al. [11] found that Cdc42 activation regulates lymphocyte
chemotaxis. Guo et al. meanwhile, [12] showed that Cdc42
maintains naïve T cell homeostasis through promotion of
cell survival and suppression of T cell activation.is is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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ulated by interleukin (IL)-1β, interferon-gamma (IFN-γ),
and tumor necrosis factor-alpha (TNF-α) [13]. The TNF
superfamily causes recruitment of several intracellular
adaptors, such as Fas, to activate multiple signal transduc-
tion pathways that induce apoptosis [14]. The eventual fate
of the cell is dependent on integrated signals received
through the antigen receptor, co-stimulatory receptors,
cytokine receptors and members of the TNF receptor fam-
ily, with these signals being highly specialized to promote
either the survival or death of the cell, and thus eventually
to return the immune response to a state of homeostasis.
Identifying proteins that normally regulate immune re-
sponse and decrease apoptosis in diabetics offers the op-
portunity to develop novel therapeutic strategies. Whey
proteins (WP) has been postulated to reduce the effects of
oxygen radicals by increasing glutathione [15-18], which
stimulates lymphocyte proliferation, increases mast cells
and their associated cytokines and biochemical mediators,
and enhances the humoral immune response. Further-
more, a recent study has successfully determined the role
of WP in restoring the normal inflammatory phase of the
wound healing process in diabetic models [15] and the
proliferation of PBMC [16]. WP is easily available from
different milk sources, especially camels, in Saudi Arabia.
The current study builds on this work by assessing
whether WP can influence the outcome and progression
of diabetic immune defects. Specifically, we investigated
the impact of WP on ß cell functions and on lymphocyte
activation and proliferation in an animal model of T1D.
Materials and methods
Preparation of un-denatured camel milk whey proteins
The milk was skimmed by centrifugation at 5000 g for 20
min using an IEC Model K centrifuge [Boston, USA].
Skim milk was acidified to pH 4.3 using 1M of HCl. The
precipitated casein was removed by centrifugation, and
the supernatant containing the whey protein was saturated
with ammonium sulfate (70% saturation) and incubated
overnight at 4°C. The precipitated whey proteins were col-
lected by centrifugation and dialyzed against distilled
water for 48 h at 4°C using a Spectra/Pro® Membrane,
MWCO 6000-8000 Da. The obtained dialyzate was lyoph-
ilized using a Unitop 600 SL, [Virtis Company, Gardiner,
New York 12525 USA] and were kept at -20°C until use.
The dialyzate containing un-denatured whey proteins
were freeze-dried and refrigerated until use.
Ethical approval
Camel milk was obtained from a camel breed (Majaheem)
from the Najd region (Alazeria farm; GPS: 300 02 47/ 300
02 27) in Saudi Arabia. Specific permissions were not re-
quired for activities in this private farm. This study did not
involve endangered or protected species. Regardingexperimental animals, all procedures were conducted in ac-
cordance with the standards set forth in the guidelines for
the care and use of experimental animals by the Committee
for the Purpose of Control and Supervision of Experiments
on Animals and the National Institutes of Health. The
study protocol (care and handling of experimental animals)
was approved by the Animal Ethics Committee of the
Zoology Department in the College of Science at King Saud
University.
Diabetic models
Diabetes was induced by a single injection of freshly dis-
solved STZ (60 mg/kg of body weight; Sigma, USA) in a
0.1 mol/l citrate buffer (pH 4.5) into the peritoneum [19].
Control rats were injected with citrate buffer. Seven days
after STZ injection, the rats were screened for serum glu-
cose levels. Rats with a serum glucose level ≥ 200 mg/dl
after 2 h of glucose intake were considered diabetic and
selected for further studies.
Experimental diet
Rats were supplemented with whey protein in the diet as
previously described [20-22]. To prepare 500 g of the
diet, 5 g vitamins, 25 g mineral salts, 40 g fats, 50 g su-
crose, 100 g protein (20% protein) and 280 g starch were
mixed. Casein was the protein source in both the control
and the diabetic groups. The un-denatured camel milk
whey protein was the protein source in the WP-treated
diabetic group. The diet was kept at 4°C until use [23].
Experimental design
A total of 45 male rats (12-week-old), weighing 120-
150 g each, were obtained from the Central Animal
House of the Faculty of Pharmacy at King Saud Univer-
sity. All animals were allowed to acclimatize in metal
cages inside a well-ventilated room for 2 weeks prior to
the experiment. Animals were maintained under stand-
ard laboratory conditions (temperature at 23°C, relative
humidity was 60%–70% and a 12-h light/dark cycle) and
were fed a diet of standard commercial pellets and given
water ad libitum. Animals were distributed into three ex-
perimental groups (n = 15/group): group I was daily
administered 1% carboxymethyl cellulose (CMC), group
II diabetic rats (DM) was supplemented with distilled
water (250 μl/rat/day) for five weeks and group III
was supplemented with camel milk un-denatured WP
(DMWP) (100 mg/kg/body weight dissolved in 250 μl/
day) for five weeks. Rats of the third group were freely
supplemented with camel milk un-denatured whey pro-
teins as a protein constituent of the diet. An additional
supplementary group of normal rats treated with WP
was studied for confirming the results of the three main
groups. However, data from these groups are not in-
cluded in this study.
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The animals from all groups were autopsied under light
ether anesthesia. At the end of the experimental period,
blood was drawn from the animals by puncturing retro-
orbital venous sinus with capillary tubes until killing. Sera
were used for the determination of glucose level. After col-
lection of blood samples, the animals from all groups were
autopsied under light ether anesthesia. Subsequently,
spleen was excised from surrounding tissues and parts
were placed into tubes with fixatives (10% formalin) for
histological and immunochemical studies. Other splenic
parts were placed in buffers for lymphocytes isolation.
Estimation of glucose and insulin concentration
Serum glucose concentration was determined according
to the Trinder method [24] using a commercial diagnos-
tic kit (Biodiagnostics, Egypt). Serum insulin was assayed
using a DPC radioimmunoassay kit (Diagnostic Products
Corporation, Los Angeles, USA) [coat-A-count] accord-
ing to the method reported by Marschner et al. [25].
Lymphocyte isolation
Rats were anesthetized and euthanized; spleen was taken
out immediately and rinsed with cold phosphate buffered
saline and then placed on a 200-mesh stain steel sieve and
grounded with plunger of glass syringe. Two volume of iso-
lated lymphocyte separation medium was added, mixed gen-
tly, and centrifuged at 2,000 × g for 10 min. The top layer
was discharged leaving the middle lamella layer, showing
milk cream color, contained lymphocytes. Five volume of
PBS buffer was added and centrifuged at 1,000 × g for 5 min.
Precipitated lymphocytes were re-suspended in RPMI-1640
medium (making the final concentration of 1 × 106 cells/
mL). The viability of lymphocytes was analyzed using trypan
blue, and in all acceptable preparations, it exceeded 95%.
T and B lymphocyte proliferation assay
The proliferation was determined in sterile flat-bottomed
96-well culture plate. Lymphocyte suspension was on the
plate, then RPMI-1640 medium containing concanavalin
A (Con A, making the final concentration of 5 mg/L for T
cell or 10 mg/L lipopolysaccharide for B cells) was added
and incubated at 37°C under 5% CO2 for 24 h. Then, 20
μL MTT (5 g/L) was added to each plate and incubated for
another 4 h. The supernatants were sucked and discarded;
150 μL of dimethyl sulfoxide was added to each plate and
shaken. The optical absorbance at 490 nm was recorded in
an ELISA plate reader as previously described [26,27].
There were ten replicates for each rat lymphocytes.
Immunohistochemical detection of proliferated cell
nuclear antigen (PCNA), T and B cells
Spleen samples were fixed in 10% neutral buffered forma-
lin Paraffin sections were cleared in xylene, rehydrated ingraded ethanol (100%-70%), immersed in water for 5 to 10
minutes, and incubated in 0.3% H2O2 in 70% methanol for
20 minutes to inhibit endogenous peroxidase activity. The
specimens were then rinsed three times for 5 minutes in
PBS, and epitopes were unmasked by boiling in citrate
buffer (pH 6.0) for 15 minutes, when necessary. The sec-
tions then were blocked for 60 minutes in 3% BSA in PBS
or in 1% normal goat serum and 3% non-fat milk. Section
were incubated with primary antibodies (Anti-PCNA
[Novo Castra NCL-PCNA], anti-CD3; pan T cells or anti-
CD20; pan B cells) in 0.1% BSA overnight at 4°C in a hu-
midified chamber. Samples were then rinsed in PBS and
incubated with biotinylated secondary antibody in 0.1%
BSA for 1 hour at room temperature, followed by avidin
biotin amplification (ABC Elite) for 30 minutes. Sections
were developed with 3,3-diaminobenzidine peroxidase sub-
strate (Sigma). Sections were counterstained with Mayer
haematoxylin for 3 minutes and mounted. Negative con-
trols were set by substituting the primary antibody with
PBS [28]. Photographs of the sections were taken; the im-
ages were digitized using Adobe Photoshop (Adobe Sys-
tems, Mountain View, CA). The PCNA (the number of
brown stained cells), anti-CD3 or anti-CD20-stained cells
were determined at 20 random locations within the spleen
follicles and the PALS for each animal from each group
using a Leica Qwin 500 image analyzer.
RNA extraction and RT-PCR
RNA was extracted from the collected samples (RNA lat-
ter) using RNeasy Mini Kit (QIAGEN) according to the
manufacturer instructions. RT-PCR was performed using
QIAGEN One Step RT-PCR kit as directed by the manu-
facturer’s instruction manual. The desired genes were
amplified using specific primers (e-oligos, Hawthorne,
USA) listed in Table 1. For each sample, 25 μl reaction
mixture was performed. PCR reaction was carried out
using Gene-Amp 9700 thermal cycler. RT-PCR products
were analyzed in 1.2 % agarose gel. PCR conditions were
optimized to allow semiquantitative comparisons of re-
sults, as previously described [29]. The levels of the three
mRNA and β-actin mRNA were quantified by gel electro-
phoresis and densitometry. mRNA levels were normalized
versus β-actin and are expressed in arbitrary units.
Quantification of mRNA expression by real-time poly-
merase chain reaction cDNA from the above preparation
was subjected to PCR amplification using 96-well optical
reaction plates in the ABI Prism 7500 System (Applied
Biosystems®). The 25-μl reaction mixture contained 0.1 μl
of 10 μM forward primer and 0.1 μl of 10 μM reverse
primer (40 μM final concentration of each primer), 12.5 μl
of SYBR Green Universal Mastermix, 11.05 μl of nuclease-
free water, and 1.25 μl of cDNA sample. The primers
used in the current study were chosen from pubmed.
com. The RT-PCR data was analyzed using the relative
Table 1 List of primers used to amplify the desired genes
Primer name 5′——————— < 3′ Primer length
IL-2 Forward CCTGAGCAGGGAGAATTACA 20
Reverse TCCAGAACATGCCGCAGA 18
Fas Forward GAGAATTGCTGAAGACATGACAATCC 26
Reverse ATGGCTGGAACTGAGGTAGTTTTCAC 26
Akt1 Forward CCTTTATTGGCTACAAGGAACGG 23
Reverse GAAGGTGCGCTCAATGACTG 20
CD28 Forward GTATTCCTACAACCTTCTCGCAA 23
Reverse GGGGCTGATAGGTAAAATTCCCA 23
Cdc42 Forward TTCTGGTTGTGTTTCAACTGCT 22
Reverse CCTCCCTTGGACTGCATCTG 20
Inf- γ Forward GCCCAATATCTCGGATGCTTC 21
Reverse GCCAAAATAGCTTCGGTAATCCT 23
TNF-α Forward CCAACATGCTGATTGATGACACC 23
Reverse GAGAATGCCAATTTTGATTGCCA 23
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tems® User Bulletin No. 2. The data are presented as
the fold change in gene expression normalized to the
endogenous reference gene and relative to a calibrator.
Statistical analysis
The statistical analysis was performed using the MINITAB
software (MINITAB, State College, PA, Version 13.1, 2002).
The data from the experiments were tested for normality
using the Anderson Darling test, and for variance homo-
geneity prior to any further statistical analysis. The data
were normally distributed with homogeneous variances.
Thus, the one-way ANOVA statistical measure was used to
determine the overall effect of each treatment. This meas-
ure was supplemented by individual comparison between
the different treatments using Tukey’s method for pairwise
comparisons. The results were expressed as arithmetic
mean (M) ± standard deviation (SD). Only statistically sig-
nificant differences with P < 0.05 were found between the
treatment group and the control, and between the treat-
ment group and the diabetic group considered.
Results
WP restores Akt1, Cdc42 and CD28 signaling during
diabetes
To assess whether WP supplementation could influence
T-cell survival, activation and proliferation in T1D, we in-
vestigated the mRNA expression of Akt1, CD28 and
Cdc42. mRNA expression of the activated lymphocytes
showed that diabetes impaired the Akt1 (234 ± 9.5), CD28
(229 ± 14) and Cdc42 (33 ± 6.5) signaling compared to
those of the control group [Akt1 (252 ± 12), CD28 (235 ±
10), Cdc42 (45 ± 5.0)]. WP supplementation, however, was
found to restore mRNA expression of Akt1 (255 ± 16),CD28 (240 ± 14) and Cdc42 (47 ± 4.0) close to the normal
level (Figure 1a,b,c,d). Up-regulation of Akt1, Cdc42 and
CD28 expression was also evident in diabetic rats supple-
mented with WP.
WP activates lymphocyte proliferation in diabetic rats in
vivo and in vitro
To validate these observations and to determine the effect
of WP on lymphocyte activities, lymphocytes from the
WP-treated diabetic rats, the diabetic and the control
groups were isolated and examined for cell proliferation.
Viability of the lymphocytes was measured by trypan blue
exclusion test. Approximately 80% lymphocytes of diabetic
rats were killed in medium during 72 hours of incubation
comparing to the control rats (Figure 2a). Non-significant
changes of the lymphocytes derived from WP-treated dia-
betic rats comparing to the control rats (Figure 2a). The
mitogen stimulated (Con A or LPS) lymphocytes derived
from WP-treated diabetic rats demonstrated significantly
higher proliferative activity (90% or 110%, respectively) as
compared to those from the diabetic rats (50% or 45%, re-
spectively) (Figure 2b,c).
To examine the impact of WP on lymphocyte prolifera-
tions further, spleen sections were stained with PCNA
antibodies. PCNA-stained sections appeared to exhibit
minimal proliferation activity in diabetic group compared
to the control group (Figure 3). Lymphocytes stained with
PCNA antibodies in the germinal centers of follicles from
WP-treated rats showed very high proliferation activity
(Figure 3). Periarteriol lymphatic sheath (PALS) cells (al-
most T cells) from WP-treated rats, showed a significantly
higher capacity (35 ± 4.55) for proliferation than those of
diabetic animals (2.0 ± 0.06) (Figure 3). In spleen follicle,
cells from WP-treated rats, showed more than twenty
Figure 1 Quantitative analysis of mRNA expression of AKT1 genes (a). Semiquantative PCR-mRNA expression of Akt1 (b), CD28 (c) and
Cdc42 (d) of the antigen activated lymphocytes from control, DM and DMWP rats. PCR products were separated and visualized by DNA agarose
electrophoresis after amplification of Akt1, CD28 and Cdc42 from splenocyte genomic DNA. Samples from five animals were analyzed. A
representative result from each group is presented, while the values in the histograms are the mean ± SD. *shows the significance (p < 0.05) in
comparison to the control group. #shows the significance (p < 0.05) in comparison to the diabetic group.
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than those of diabetic animals (4.0 ± 0.78) (Figure 3).
WP forces survival of B lymphocytes and strongly
suppresses T cells
Following the observed mitogenic activity of WP shown
previously in this work, we determined the extent to
which both B and T cells were activated by this protein.
Spleen sections were stained with anti-CD20 or anti-CD3antibodies to realize B or T cells, respectively (Figure 4a-f).
Figure 4g shows that the number of B cells was signifi-
cantly (P < 0.05) reduced in both the marginal zone and
lymphatic follicles of the diabetic rats (25 ± 1.5) compared
to the control group (31 ± 1.4). On the other hand, the
number of B cells in diabetic rats supplemented with WP
were significantly (P < 0.05) increased (94 ± 4.59) in both
the marginal zone and lymphatic follicles compared to the
diabetic and the control rats, respectively (Figure 4g).
Figure 2 MTT assay for the cell viability percentage of control
splenocytes (a). Splenic lymphocytes were co-cultured with
mitogen [suspension containing con. A for detecting activity of T cell
(b) or LPS for detecting activity of B cells (c)] for 48 h and then
harvested for analysis with the MTT method.
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extensively distributed in all zones, especially in the PALS,
in the spleen sections of the diabetic rats (Figure 5c,d) (2.5-
fold compared to the control group). WP was found to sig-
nificantly (P < 0.05) reduce these T cells (20 ± 3.1) one fifth
and one half their number in the diabetic (107 ± 11) and
control (39 ± 3.6) groups, respectively (Figure 5g).
WP increases polyfunctional T cells and down regulates
mRNA expression of TNF-α and Fas during diabetes
After exploring the impact of WP on the proliferative ac-
tivity of both T and B cells the polyfunctional activity of T
cells was investigated by detecting the expression of two
important cytokines, IFN-γ and IL-2-mRNA. As shown in
Figure 6a,b, mRNA expression of IFN-γ, which has a crit-
ical role in intracellular immune activity, was significantly
(P < 0.05) impaired in the diabetic rats [4 (Figure 6a) and2-fold (Figure 6b) reduced compared to the control
group]. IFN-γ concentration detected by ELISA showed
similar behavior in diabetic group (Figure 6c). IFN-γ
mRNA in diabetic rats supplemented with WP were sig-
nificantly (P < 0.05) 3-fold (15 ± 2.67) increased compared
to the diabetic rats (5.0 ± 1.1) (Figure 6a).
In regard to the mRNA expression of IL-2, however, no
significant difference was observed between the diabetic
and control groups (Figure 6d) despite its protein level
was significantly (P < 0.05) lowered (Figure 6e). Although
WP minimized the number of T cells in the splenic tis-
sues, WP was found to significantly restore the number of
polyfunctional T cells (i.e. IFN-γ and IL-2-producing cells).
WP was found to significantly (P < 0.05) elevate the mRNA
expression of IL-2 (250 ± 12.7) compared to the diabetic
(148 ± 6.8) and control (119 ± 4.9) groups (Figure 6d).
To validate this data and to ascertain the impact of WP
on the pancreatic ß-cell mass, we observed mRNA expres-
sion of TNF-α and one of its receptors (Fas), which, to-
gether with inflammatory cytokines, are the key factors in
the destruction of ß-cell mass in T1D. The mRNA expres-
sion of TNF-α was significantly increased in diabetic rats
(309 ± 14.55) but, in contrast, WP treatment was found to
normalize the mRNA expressions of this gene (220 ± 9.11)
(Figure 6f). By ELISA, WP was found to significantly re-
duce TNF-α (Figure 6g). The mRNA expression of Fas
was significantly increased in diabetic rats (164 ± 7.29)
compared to the control group (2.0 ± 0.034) (Figure 6h).
WP normalizes the structure and function of pancreatic
ß cells
Furthermore, the histological structure of the pancreas
from the three different groups was investigated to assess
whether there were any observable impacts on the diabetic
rates of supplementation with WP. While degenerative
changes in the nuclei of the pancreatic ß-cells were ob-
served in the microscopic sections of the untreated diabetic
rats, with nuclei appearing darkly stained with fragmented
chromatin (Figure 7b), in those animals treated with WP,
more normal morphological features of the pancreatic ß-
cells were restored (Figure 7c).
An improvement in the pancreatic cell function was also
found. WP supplementation improved glucose clearance,
enabling the basal plasma glucose concentration in those
diabetic animals treated with WP to be significantly (P ≤
0.005) normalized to the concentration levels in the con-
trol animals (Figure 7d). This confirmed that insulin re-
lease from the pancreatic islets was restored to normal
levels (24 ± 2.6) in diabetic rats supplemented with WP
(26 ± 2.28) (Figure 7e).
Discussion
Inflammatory cytokines stimulate multiple signaling cas-
cades leading to ß cell apoptosis [13] in T1D [29]. By
Figure 3 Spleen sections were stained with PCNA antibodies (×400) to show proliferation activity in control (a), DM (b), DMWP (c)
spleens showing the brown proliferating cells in the PALS and germinal centers (GC). Values shown are the mean count of the
proliferating cells in both PALS (d) and GC (e) ± SD. *shows the significance (p < 0.05) in comparison to the control group. #shows the significance
(p < 0.05) in comparison to the diabetic group.
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capacity of diabetic [15,17] animals to heal wounds. Po-
tential effects of WP on immune processes, including
the regulation of cytokines [30] and enhancement of the
proliferation capability of PBMCs [16] have been ob-
served. WP, therefore, can not only suppresses the in-
flammatory cytokines from autoreactive T cells but also
restore normal ß-cell mass and function during diabetes.In this study diabetes was found significantly to impair
the proliferative response of splenic lymphocytes in vivo
and antigen-stimulated lymphocytes in vitro. Indeed, we
did not observe any significant proliferation activities in
the PALS zone, which are provoked by CD4+ T cells.
Similarly, Aarnisalo et al. [31] found a marked reduction
in the proliferative response of CD4+ T cells among pa-
tients with T1D.
Figure 4 Spleen sections stained with anti-CD20+ antibodies to realize B cells. It shows the marginal zone and lymphatic follicles in the
control (a, b), DM (c, d) and DMWP (e, f) groups. The number of B cells was reduced in the marginal zone (MZ) and lymphatic follicles (F) of the
diabetic rats and increased in both areas in WP treated diabetic rats (×400). Values shown are the mean count of the CD-20 cells in both MZ and
F (g) ± SD. *shows the significance (p < 0.05) in comparison to the control group.
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lymphocytes in splenic follicles showed highly significant
proliferating activity, and this was confirmed in vitro. Al-
though WP activates cell proliferation, therefore, stainingwith anti-PCNA antibodies showed that this proliferation
was located in the B cell zone but not in the T cell zone of
the splenic tissue. The proliferation activity stimulated by
WP, therefore, was directed toward B cells rather than T
Figure 5 Spleen sections stained with anti-CD3+ antibodies to realize T cells. It shows the marginal zone and lymphatic follicles in the
control (a, b), DM (c, d) and DMWP (e, f) groups. T cells are strongly distributed in all zones, especially PALS, in the spleen sections of the
diabetic rats. Interestingly, WP greatly reduced the number of T cells in the tissues of diabetic rats (×400). Values shown are the mean count of
the CD-3+ cells in both MZ and F (g) ± SD. *shows the significance (p < 0.05) in comparison to the control group.
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CD20+ and anti-CD3+ antibodies which demonstrated that
the number of B cells was greatly increased but that the
number of T cells was reduced in the tissues of the WP-
treated diabetic rats compared with untreated diabetic rats.This provides further evidence that WP is associated with B
cell stimulation and T cell suppression during diabetes.
Our results suggest that WP may suppress the Th1
type of T cell that has a critical role in diabetic complica-
tions. This suggestion was practically confirmed by the
Figure 6 Quantitative analysis of mRNA expression of AKT1 genes (a). Semiquantative PCR-mRNA expression and the supernatant levels of
IFN-γ (b, c) and IL-2 (d, e). It was found that WP restores the polyfunctional T cells (IFN-γ and IL-2 producing cells that exhibit a high proliferation
capacity). The mRNA expressions (f) and the supernatant level (g) of TNF-α, and the mRNA expressions of Fas (h). Samples from five animals were
analyzed. Samples from five animals were analyzed, while a representative result from each group is presented in this figure. Values shown are
mean values ± SD. *shows the significance (p < 0.05) in comparison to the control group. #shows the significance (p < 0.05) in comparison to the
diabetic group.
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Figure 7 Representative microscopic sections of the control (a), DM (b) and DMWP (c) rats (E&H × 400). Plasma glucose (d) and insulin (e)
concentration of the control, DM and DMWP rats. *shows the significance (p < 0.05) in comparison to the control group. #shows the significance
(p < 0.05) in comparison to the diabetic group.
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homeostasis of naïve T cells by promoting cell survival
and suppressing T cell activation [12]. Cdc42-deficient
naïve T cells display impaired actin polymerization and
show an enhanced differentiation to Th1 and CD8+ ef-
fector and memory cells [12]. Restoring Cdc42 by WP
may, therefore, maintain the balance between the Th1
and Th2 subsets of T cell by specifically suppressing T
cell activation and differentiation to Th1 and CD8+ ef-
fector and memory cells. Ultimately, this T cell homeo-
stasis results in an improvement in the condition of the
pancreatic ß cells.
Akt is critical for cell survival and is triggered by differ-
ent stimuli [32]. WP supplementation was found to re-
store mRNA expression of Akt1 to the normal level. It
was also shown in this work that up-regulation of Akt1
was accompanied by a significant increase of lymphocyteproliferation in the splenic tissues. The mRNA expression
of the activated lymphocytes showed that diabetes had de-
creased the Akt1 signaling. Inhibition of cell migration has
also been shown to be effected by inhibition of phospho-
rated PI3K/Akt, resulting in rapid Cdc42 proteolysis [33].
These studies confirm that Akt depletion impairs the
mRNA expression of Cdc42 by activated lymphocytes dur-
ing diabetes. Taken together, the results of our study con-
firm that WP linked up-regulation of Akt1 significantly
elevates Cdc42 and this enhances T cell homeostasis but
not ß cells attacking Th1 cells.
Cell death stimuli signals are either an intrinsic, mito-
chondrial pathway of apoptosis or can kill the cell
through one of the six death receptors such as Fas [1].
Fas was significantly up-regulated in diabetic rats, as
shown by the high number of dead lymphocytes in the
diabetic group, suggesting that diabetic complications
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regulation [34,35]. The increased expression of Fas in
the diabetic lymphocytes was, however, significantly
inhibited by WP treatment. This indicates that WP re-
stored T cell homeostasis by suppressing T cell prolifer-
ating activity rather than through the Fas-mediated
apoptotic pathway.
Turning now to CD28, we found a lower level of CD28
expression on antigen-stimulated lymphocytes in the dia-
betic group while this level was restored in diabetic rats
treated with WP. Recent studies have demonstrated that a
significantly lower level of CD28 surface expression on T
cells was detected in diabetic rats, children with T1D, cell
leukaemia, chronic lymphocytic leukaemia and colorectal
cancer [36-38]. CD28 may contribute to T cell viability by
increasing glucose metabolism in activated T cells [39].
CD28 signals are also required to protect T cells from Fas-
mediated apoptosis by activating the PI3K/Akt pathway
[40]. Thus, a lower level of CD28 surface expression on T
cells from diabetic rats could explain the observed two-
fold higher level of dead cells in the diabetic group. In the
absence of co-stimulation, cytokine secretion and T cell
expansion, proliferation, survival and memory develop-
ment are affected [41,42]. The diabetic rats in our study
also exhibited decreased IL-2 or IFN-γ expression, which
is a major T cell function. On the other hand, it is likely
that the higher level of CD28 surface expression in the
WP-treated animals causes the higher viability and prolif-
erating capacity, and the restoration of IL-2 and IFN-γ
levels.
WP suppresses TNF-α production, which is the key fac-
tor in ß cell-destruction in T1D since TNF-α controls the
expression of the inflammatory gene network and contrib-
utes to the pathological complications observed in many
inflammatory diseases such as schizophrenia and diabetes
[43,44]. Therefore, while the higher expression of TNF-α
caused pancreatic damage and dysfunction in the diabetic
group in this study, WP was found to regulate expression
of TNF-α and its apoptosis receptor, Fas to normal levels.
By increasing glutathione, WP also induces oxidative sta-
bility leading to suppression of the inflammatory cascade
[15]. Since blocking the production of TNF-α improves
blood glucose concentrations, targeting TNF-α could
effectively reduce expressions of the primary factors be-
hind the complications associated with diabetes [45].
Thus, normal morphological features of the pancreatic
ß-cells and glucose clearance were restored in the dia-
betic rats treated with WP due to the suppression of
TNF-α. The hypoglycaemic effect of WP in individuals
with T1D has recently been confirmed [46,47] and WP
has also been shown to restore the capacity of the
pancreatic islet to secrete insulin [48]. Here, we add to
this picture of the beneficial effects of WP in the con-
text of diabetes by showing that WP supplementationfor five weeks in normalized glucose clearance in dia-
betic rats.
In conclusion, we have shown here that there is a
strong, positive correlation between WP and immune
function during diabetes in an animal model. WP re-
stored the normal immune response as follows: 1) by
activating the Akt1 pathway, it activated the CD28 sig-
nals required to protect T cells from Fas-mediated
apoptosis; 2) by stimulating Cdc42, which maintains
naïve T cell homeostasis by promoting cell survival and
suppressing T cell activation. This leads to the restor-
ation of the polyfunctional T cells (IFN-γ and IL-2 pro-
duction), increased cell viability, and may restore the T
cell subset balance; 3) by suppressing TNF-α and its re-
ceptor, Fas. The positive outcome of this range of effects
at the cellular level are confirmed by our evidence on
improvements of the pancreatic ß cell mass and func-
tion. There is a need, however, to investigate more in-
tensively the potential role of WP in the treatment of
diabetic immune impairment.
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